Clinical drug development Archives

News & Features

AstraZeneca’s Durvalumab Granted Priority Review for Form of Small Cell Lung Cancer

Chris Anderson -

August 16, 2024

News & Features

New Glioma Drug Approved for First Time in Decades

Malorye Branca -

August 8, 2024

Transparent blue image of human heart with monitored beat, which can be abnormal in people with long QT syndrome

News & Features

Lilly’s Tirzepatide Improves Heart Failure Outcomes

Helen Albert -

August 1, 2024

3D image illustrating immune cells attacking cancer cells in immunotherapy such as that used in cancers with mismatch repair deficiency

News & Features

BioNTech’s mRNA Vaccine Combo Scores in Phase II

Malorye Branca -

August 1, 2024

News & Features

Cardurion Raises $260M to Advance Novel CV Drugs

Malorye Branca -

July 23, 2024

News & Features

Roche Oral GLP-1 Agonist Scores in Early Trial

Malorye Branca -

July 19, 2024

Cancer cell surrounded by therapeutic antibodies and cytokines among normal cells

News & Features

Vertex and Orum Launch $945M+ Collaboration to Replace Chemotherapy with DAC

Alex Philippidis -

July 17, 2024

News & Features

Promising Early Results from Lexeo’s Gene Therapy for Friedreich Ataxia Cardiomyopathy

Malorye Branca -

July 16, 2024

News & Features

New Cellular Immunotherapy Shows Promise against Solid Tumors in Phase II Trial

Chris Anderson -

July 12, 2024

News & Features

IDEAYA’s MAT2A Inhibitor Scores in Phase II for Urothelial and NSCLC

Malorye Branca -

July 11, 2024

12 3...17 Page 1 of 17

Study Sheds Light on How Aging Immune System Drives Cancer Development

Gastrointestinal Chemotherapy Tweak Can Reduce Side Effects

eGenesis Raises $191 Million for Gene Edited Pig Organs

Potassium Isotopes Could Provide Early Diagnosis of Alzheimer’s

Mobile Phone Use May Increase Risk of Cardiovascular Disease

Clinical drug development

AstraZeneca’s Durvalumab Granted Priority Review for Form of Small Cell Lung Cancer

New Glioma Drug Approved for First Time in Decades

Lilly’s Tirzepatide Improves Heart Failure Outcomes

BioNTech’s mRNA Vaccine Combo Scores in Phase II

Cardurion Raises $260M to Advance Novel CV Drugs

Roche Oral GLP-1 Agonist Scores in Early Trial

Vertex and Orum Launch $945M+ Collaboration to Replace Chemotherapy with DAC

Promising Early Results from Lexeo’s Gene Therapy for Friedreich Ataxia Cardiomyopathy

New Cellular Immunotherapy Shows Promise against Solid Tumors in Phase II Trial

IDEAYA’s MAT2A Inhibitor Scores in Phase II for Urothelial and NSCLC

Related Content

Nano Delivery of Drug Combo Shrinks Pancreatic Cancer Tumors in Mice

Olaparib Monotherapy: A Promising Option for Biochemically Recurrent Prostate Cancer?

Global Trial of BioNTech’s mRNA-Based Lung Cancer Vaccine Launches

Overriding Tumor Gene Self-Edits to Improve Immunotherapies